We are live on ! Find out more

179 hedge funds and large institutions have $1.38B invested in Neogen in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 62 increasing their positions, 76 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

296% more call options, than puts

Call options by funds: $1.52M | Put options by funds: $384K

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

2% more funds holding

Funds holding: 175179 (+4)

0% less capital invested

Capital invested by funds: $1.39B → $1.38B (-$5.15M)

18% less repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 76

Holders
179
Holders Change
+4
Holders Change %
+2.29%
% of All Funds
5.15%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
14
Increased
62
Reduced
76
Closed
8
Calls
$1.52M
Puts
$384K
Net Calls
+$1.14M
Net Calls Change
+$320K

NEOG Hedge Fund Activity: Q1 2014 in Review

179 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Neogen (NEOG) for Q1 2014, worth a combined $1.38B — down 0.37% from $1.39B a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new NEOG positions and 8 closed out — a net gain of 6 holders — while 62 added to existing stakes and 76 trimmed.

The largest buyer was Conestoga Capital Advisors, adding an estimated $12.5M. The largest seller was Bank of New York Mellon, cutting an estimated $6.82M.

  • 179 institutional investors held Neogen (NEOG) as of Q1 2014, up from 175 in Q4 2013.
  • Funds reported $1.38B of Neogen stock for Q1 2014, down 0.37% quarter-over-quarter.
  • 14 funds opened new Neogen positions in Q1 2014 and 8 closed out, a net change of +6 holders.
  • The largest Neogen buyer in Q1 2014 was Conestoga Capital Advisors, an estimated $12.5M added.
  • The largest Neogen seller in Q1 2014 was Bank of New York Mellon, an estimated $6.82M sold.

Based on aggregated 13F filings for Q1 2014.